According to Citius Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ4.25. a decrease over its 2023 EPS that were of -ยฃ4.31.
Year | EPS | Change |
---|---|---|
2024 | -ยฃ4.62 | 7.18% |
2023 | -ยฃ4.31 | -3.13% |
2022 | -ยฃ4.45 | -0% |
2021 | -ยฃ4.45 | -48.89% |
2020 | -ยฃ8.70 | -41.56% |
2019 | -ยฃ14.89 | -34.19% |
2018 | -ยฃ22.62 | -38.1% |
2017 | -ยฃ36.54 | -17.47% |
2016 | -ยฃ44.28 | 67.15% |
2015 | -ยฃ26.49 | |
2014 | N/A | -100% |
2013 | -ยฃ0.81 | 42.55% |
2012 | -ยฃ0.57 | |
2011 | N/A |